Alniche Lifesciences Private Limited, a active private limited company, was established on 09 November 2012 in New Delhi, Delhi, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U51909DL2012PTC244770. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.01 Cr and a paid-up capital of ₹0.13 M.
It upholds a compliant status. Employing 730 professional, Its leadership includes Girish Arora (Director), Tirunelveli Padmanabhan Devarajan (Director), Mehak Arora (Director). Past directors included Mehak Arora. It holds ₹75.39 Cr open charges and ₹37.28 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at S – 14, Second Floor, Janta Market, Rajouri Garden, New Delhi, Delhi, 110027.
U51909DL2012PTC244770
244770
09 November 2012
₹1.01 Cr
₹0.13 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Alniche Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Girish Arora | Director | 09 Nov 2012 | Current |
| Tirunelveli Padmanabhan Devarajan | Director | 31 May 2018 | Current |
| Mehak Arora | Director | 01 Dec 2015 | Current |
| Karan Arora | Director | 09 Nov 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 27 Sep 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Alniche Lifesciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.14% increase. The company also saw a substantial improvement in profitability, with a 112.9% increase in profit. The company's net worth Soared by an impressive increase of 35.65%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Alniche Lifesciences had a promoter holding of 78.37% and a public holding of 21.63%. The company had 1 Joint Venture. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹753,928,046.00
₹372,814,999.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Feb 2024 | Hdfc Bank Limited | ₹6.31 M | Open |
| 26 Feb 2024 | Hdfc Bank Limited | ₹3.31 M | Open |
| 24 Sep 2021 | Axis Bank Limited | ₹2.05 M | Open |
| 18 Apr 2019 | Axis Bank Limited | ₹1.40 M | Open |
| 04 Dec 2018 | Hdfc Bank Limited | ₹74.09 Cr | Open |
Explore comprehensive loan charge details -
Alniche Lifesciences has a workforce of 730 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Alniche Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alniche Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 28 Dec 2019 via Charge ID 100342287 with Axis Bank Limited was fully satisfied on 16 Oct 2024. was documented.
The activity Alniche Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Alniche Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
The activity A charge with Hdfc Bank Limited amounted to Rs. 0.63 Cr with Charge ID 100907371 was registered on 26 Feb 2024. was completed.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.33 Cr with Charge ID 100873111 was registered on 26 Feb 2024. was documented.
The activity A charge with Hdfc Bank Limited of Rs. 74.09 Cr registered on 04 Dec 2018 with Charge ID 100221280 was modified on 20 Sep 2023. was completed.
Under this collaboration, both the partners are working together for three broad areas: Formulation & Development, Concept to Creation and Analysis & Standardisation of differentiated novel Pharmaceuticals. .
The CIN of Alniche Lifesciences Private Limited is U51909DL2012PTC244770.
Alniche Lifesciences Private Limited is headquartered at S – 14, Second Floor, Janta Market, Rajouri Garden, New Delhi, Delhi, 110027.
Alniche Lifesciences Private Limited was incorporated on 09 November 2012.
The current directors of Alniche Lifesciences Private Limited are
The primary industry of Alniche Lifesciences Private Limited is Trade.
Alniche Lifesciences Private Limited is unlisted.
The authorized capital of Alniche Lifesciences Private Limited is ₹1.01 Cr, and the paid-up capital is ₹0.13 M.
The compliance status of Alniche Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX